Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens

Fangwen Zhang,1,2,* Ling Li,1,2,* Lei Zhang,1,2 Xin Li,1,2 Xiaorui Fu,1,2 Xinhua Wang,1,2 Jingjing Wu,1,2 Zhenchang Sun,1,2 Fei Kong,1,2 Liangliang Ren,1,2 Mingzhi Zhang1,21Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, People’s Repu...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Zhang F, Li L, Zhang L, Li X, Fu X, Wang X, Wu J, Sun Z, Kong F, Ren L, Zhang M
Format: article
Langue:EN
Publié: Dove Medical Press 2019
Sujets:
CD5
Accès en ligne:https://doaj.org/article/7b40f317ec344a0aaf7018c1756edf7e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!